Magnetar Financial’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$673K Buy
+12,068
New +$653K 0.01% 701
2026
Q2
– Sell
-12,617
Closed -$419K – 1458
2026
Q1
$419K Buy
+12,617
New +$376K ﹤0.01% 669
2024
Q4
– Sell
-18,259
Closed -$427K – 786
2024
Q3
$427K Sell
18,259
-18,494
-50% -$404K 0.01% 361
2024
Q2
$654K Sell
36,753
-15,396
-30% -$246K 0.01% 311
2024
Q1
$793K Buy
+52,149
New +$831K 0.02% 271
2023
Q3
– Sell
-43,053
Closed -$1.07M – 580
2023
Q2
$1.07M Buy
43,053
+30,358
+239% +$784K 0.02% 269
2023
Q1
$191K Buy
+12,695
New +$193K ﹤0.01% 552
2021
Q3
– Sell
-5,369
Closed -$208K – 1518
2021
Q2
$208K Buy
+5,369
New +$211K ﹤0.01% 1102

Other funds holding TGTX

Magnetar Financial's TGTX Position: Q3 2026 in Review

Magnetar Financial opened a new position in TG Therapeutics (TGTX) in Q3 2026: 12,068 shares worth $673K. The stake represents 0.01% of the portfolio and ranks #701 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in TGTX as recently as Q1 2026.

Magnetar Financial first reported a position in TGTX in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.07M in Q2 2023. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Magnetar Financial held 12,068 shares of TG Therapeutics worth $673K as of Q3 2026.
  • TG Therapeutics was a new Magnetar Financial position in Q3 2026.
  • TG Therapeutics made up 0.01% of Magnetar Financial's portfolio in Q3 2026, its #701 holding.
  • Magnetar Financial first reported a position in TG Therapeutics in Q2 2021 and has held it in 8 quarters since.
  • Magnetar Financial's TG Therapeutics position peaked at $1.07M in Q2 2023.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.